Ownership history in Navalign, LLC · 19 quarters on record
This page tracks every 13F SEC filing in which Navalign, LLC reported a position in ALLOGENE THERAPEUTICS INC (ALLO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 49,398 | -10,467 | -17.5% | 0.02% | $68K | $1.37 |
| 2025 Q3 | UNCHANGED | 59,865 | — | 0% | 0.02% | $74K | $1.24 |
| 2025 Q2 | UNCHANGED | 59,865 | — | 0% | 0.02% | $68K | $1.13 |
| 2025 Q1 | UNCHANGED | 59,865 | — | 0% | 0.02% | $87K | $1.46 |
As of 2025 Q4 — sorted by position size